Compliance with
European regulations

VedaLab

Distribution in
170 + countries

VedaLab

ISO 13485
certified company

VedaLab

POC European
leader

VedaLab

New products

COVID-19-CHECK-1 ANTIGEN

COVID-19-CHECK-1 ANTIGEN

Immunochromatographic rapid test for the qualitative detection of SARS-CoV-2 virus in nasopharyngeal swab samples. The COVID-19-CHECK-1 Antigen test is a […]

Read more
ROTADENO-Screen®

ROTADENO-Screen®

Home use rapid test for the detection of Rotavirus and/or Adenovirus in feces. This test is now CE marked. Refer […]

Read more

Exhibition

MEDICA EXHIBITION

MEDICA EXHIBITION

We will exhibit at MEDICA exhibition from November 15th to 18th, 2021 in DUSSELDORF, Germany. We will be pleased to […]

Read more

Information

Syphilis Health Check

The Syphilis Health Check test manufactured by VEDALAB has been granted by FDA on December 15th, 2014 the first-ever CLIA […]

Read more

Ebola Rapid Test

VedaLab is very proud to announce that, in collaboration with the CEA (Commissariat à l’Energie Atomique), its very reputable R&D […]

Read more
VedaLab

VEDALAB is a privately French owned company, founded in 1991.  

It is devoted to the development, production and marketing of in vitro immunodiagnostic rapid tests. As a  market leader, VEDALAB focuses on international expansion by forming long-term partnerships with reliable and trustworthy distributors worldwide.  Continually expanding its impressive range of products, VEDALAB is today the biggest rapid test manufacturer in Europe.

Learn more